Professor Xenofon Baraliakos, EULAR president-elect, discusses personalised treatment and other challenges and opportunities ...

Researchers discover how mitochondria not only produce energy but also influence inflammation.

The clever term was coined “to describe the low-grade, chronic inflammation that accumulates in our bodies as we age and ...

It can be easy to use soreness as an excuse to jumble up your gym routine. But the saying “no pain, no gain,” may have some ...

The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...